{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T14:55:50Z","timestamp":1763823350431,"version":"3.45.0"},"reference-count":41,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[2025,6,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The incidence of metabolic dysfunction\u2010associated steatohepatitis (MASH) and associated liver fibrosis is rapidly increasing, while pharmacological treatment options remain limited. Despite great efforts in developing novel MASH therapeutics, many investigative therapeutics that reduced fibrosis in preclinical models ultimately failed in clinical trials. To this end, we explored the possibility of predicting the efficacy of therapeutics by evaluating changes in the expression of a fibrogenic gene signature in the early stages of disease development and before effects on pathology become evident. Ldlr\u2212\/\u2212.Leiden mice were fed a high\u2010fat diet (HFD) to induce obesity and MASH. Mice were subsequently treated for 4\u2009weeks with various therapeutics with established efficacy (obeticholic acid) or lack of efficacy (cenicriviroc and pioglitazone) to study their anti\u2010fibrotic potential. Expression of a fibrogenic gene signature was evaluated, which predicts profibrotic processes before histopathologic fibrosis develops. The predictions were compared with a long\u2010term experiment reaching histological fibrosis endpoints. Cenicriviroc and pioglitazone did not affect HFD\u2010induced fibrosis signature, indicative of no effect of these treatments on active fibrosis processes. Consistently, in the long\u2010term treatment study, both cenicriviroc and pioglitazone did not affect HFD\u2010induced histologically measured fibrosis. In contrast, obeticholic acid improved the fibrogenic gene signature to a healthier state compared to untreated HFD controls. These early gene expression changes aligned with long\u2010term histological fibrosis endpoints and clinical data on these investigative therapeutics. This study highlights the potential of using short\u2010term studies and applying a fibrogenic gene signature as an early screening tool to investigate the efficacy of investigative drugs on MASH\u2010associated fibrosis. This signature, which is based on the active fibrosis processes in humans, may allow rapid screening of therapeutics, or combinations thereof, when used in a translational mouse model.<\/jats:p>","DOI":"10.1096\/fj.202500718r","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T04:04:30Z","timestamp":1749873870000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fibrogenic Gene Signature as Early Prediction for the Efficacy of Pharmacological Interventions for\n                    <scp>MASH<\/scp>\n                    \u2010Associated Fibrosis"],"prefix":"10.1096","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3725-6785","authenticated-orcid":false,"given":"Jos\u00e9 A.","family":"Inia","sequence":"first","affiliation":[{"name":"Department of Metabolic Health Research The Netherlands Organization for Applied Scientific Research (TNO)  Leiden the Netherlands"},{"name":"Department of Cardiology Leiden University Medical Center (LUMC)  Leiden the Netherlands"},{"name":"Einthoven Laboratory for Experimental Vascular Medicine LUMC  Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4996-943X","authenticated-orcid":false,"given":"Martine C.","family":"Morrison","sequence":"additional","affiliation":[{"name":"Department of Metabolic Health Research The Netherlands Organization for Applied Scientific Research (TNO)  Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9588-8863","authenticated-orcid":false,"given":"Arianne","family":"van Koppen","sequence":"additional","affiliation":[{"name":"Department of Metabolic Health Research The Netherlands Organization for Applied Scientific Research (TNO)  Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7713-2381","authenticated-orcid":false,"given":"Eveline","family":"Gart","sequence":"additional","affiliation":[{"name":"Department of Metabolic Health Research The Netherlands Organization for Applied Scientific Research (TNO)  Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0248-4008","authenticated-orcid":false,"given":"Martien P. M.","family":"Caspers","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Systems Biology TNO  Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0724-0897","authenticated-orcid":false,"given":"Aswin L.","family":"Menke","sequence":"additional","affiliation":[{"name":"Department of Metabolic Health Research The Netherlands Organization for Applied Scientific Research (TNO)  Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Worms","sequence":"additional","affiliation":[{"name":"Department of Metabolic Health Research The Netherlands Organization for Applied Scientific Research (TNO)  Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1350-0149","authenticated-orcid":false,"given":"Robert","family":"Kleemann","sequence":"additional","affiliation":[{"name":"Department of Metabolic Health Research The Netherlands Organization for Applied Scientific Research (TNO)  Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7847-9037","authenticated-orcid":false,"given":"Lars","family":"Verschuren","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Systems Biology TNO  Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3246-8359","authenticated-orcid":false,"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[{"name":"Department of Cardiology Leiden University Medical Center (LUMC)  Leiden the Netherlands"},{"name":"Einthoven Laboratory for Experimental Vascular Medicine LUMC  Leiden the Netherlands"},{"name":"Netherlands Heart Institute  Utrecht the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7206-1596","authenticated-orcid":false,"given":"Hans M. G.","family":"Princen","sequence":"additional","affiliation":[{"name":"Department of Metabolic Health Research The Netherlands Organization for Applied Scientific Research (TNO)  Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0408-8842","authenticated-orcid":false,"given":"Roeland","family":"Hanemaaijer","sequence":"additional","affiliation":[{"name":"Department of Metabolic Health Research The Netherlands Organization for Applied Scientific Research (TNO)  Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7077-8446","authenticated-orcid":false,"given":"Anita M.","family":"van den Hoek","sequence":"additional","affiliation":[{"name":"Department of Metabolic Health Research The Netherlands Organization for Applied Scientific Research (TNO)  Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431"},{"key":"e_1_2_9_3_1","unstructured":"US Food and Drug Administration \u201cFDA Approves First Treatment for Patients With Liver Scarring due to Fatty Liver Disease \u201d2024 accessed January 21 2025 https:\/\/www.fda.gov\/news\u2010events\/press\u2010announcements\/fda\u2010approves\u2010first\u2010treatment\u2010patients\u2010liver\u2010scarring\u2010due\u2010fatty\u2010liver\u2010disease."},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158156"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1160"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29544"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.05.018"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.01.038"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v10.i7.1047"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-2020-0159"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.04.003"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907929"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2016.11.006"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26939"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1270"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.07.014"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092014"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00132"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2016.74"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010001"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu11081861"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.05.051"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-024-01043-6"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32427"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48956-0"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2017.10.001"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.3758\/BF03203630"},{"issue":"10","key":"e_1_2_9_28_1","first-page":"1072","article-title":"Establishment of a General NAFLD Scoring System for Rodent Models and Comparison to Human Liver Pathology","volume":"9","author":"Liang W.","year":"2014","journal-title":"PLoS One"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-121808-102132"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.06.043"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25699-9"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29477"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.2337\/db19-1148-P"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41854-2"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i2.179"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26383-8"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33041-7"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61933-4"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90530-8"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12421"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.152694"}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.202500718R","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T14:51:38Z","timestamp":1763823098000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.202500718R"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,6,30]]}},"alternative-id":["10.1096\/fj.202500718R"],"URL":"https:\/\/doi.org\/10.1096\/fj.202500718r","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"type":"print","value":"0892-6638"},{"type":"electronic","value":"1530-6860"}],"subject":[],"published":{"date-parts":[[2025,6,14]]},"assertion":[{"value":"2025-03-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70735"}}